A deeper understanding of the mechanisms involved in potential alterations in the circadian clock of AL might contribute to a better understanding of leukaemia specific vulnerabilities and hence potentially ameliorate the efficacy of therapy and mitigate unwanted side effects and complications. This evidence concerns the gene CLOCK and leukemia.